Presentation
14 August 2019 Photodynamic priming and VDR activation modulate tumor-stroma interactions and permeability for durable control and enhanced treatment tolerability (Conference Presentation)
Michael Pigula, Sriram Anbil, Huang-Chiao Huang, Yan Baglo, Mans Broekgaarden, Diane Simeone, Gian Paolo Dotto, Tayyaba Hasan
Author Affiliations +
Proceedings Volume 11070, 17th International Photodynamic Association World Congress; 1107063 (2019) https://doi.org/10.1117/12.2526104
Event: 17th International Photodynamic Association World Congress, 2019, Cambridge, Massachusetts, United States
Abstract
Cancer patients often must confront the decision of whether to continue high dose chemotherapy at the expense of cumulative toxicities and high cost. Strategies to reduce the toxicity of these high dose regimens, while also retaining efficacy, have not been prioritized yet are sorely needed to preserve the performance status of these vulnerable patients. Here, we introduce a dual pronged approach to modulate the microenvironment of desmoplastic pancreatic tumors and enable significant dose de-escalation of the FDA approved frontline chemotherapeutic nanoliposomal irinotecan (nal-IRI) without compromising long-term tumor control. We demonstrate that light-based photodynamic priming (PDP) coupled with vitamin D receptor (VDR) activation targets cancer-associated microvasculature and fibroblasts to increase intratumoral nal-IRI and suppress pro-tumorigenic CXCL12/CXCR7 crosstalk. Combined optical and biochemical alteration of the tumor microenvironment enhances the efficacy of nal-IRI to enable a 75% dose de-escalation, resulting in improved tolerability with retained efficacy. Strategies aimed at modifying the tumor landscape to increase susceptibility represents a promising and relatively underexplored approach to enable dose de-escalation of toxic chemotherapeutics, and may simultaneously improve patient outcomes and quality-of-life.
Conference Presentation
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Michael Pigula, Sriram Anbil, Huang-Chiao Huang, Yan Baglo, Mans Broekgaarden, Diane Simeone, Gian Paolo Dotto, and Tayyaba Hasan "Photodynamic priming and VDR activation modulate tumor-stroma interactions and permeability for durable control and enhanced treatment tolerability (Conference Presentation)", Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 1107063 (14 August 2019); https://doi.org/10.1117/12.2526104
Advertisement
Advertisement
KEYWORDS
Tumors

Modulation

Plasma display panels

Cancer

Receptors

Resistance

Back to Top